Ltztherapeutics
Redwood City, US · Founded 2022 · 46 employees on LinkedIn · 1 known investors
LTZ Therapeutics is a clinical-stage biotechnology company developing myeloid cell-engaging immunotherapies to boost anti-tumor immunity against cancer. Its approach directs myeloid cells to kill tumor cells and reprogram the tumor microenvironment, with a lead candidate (LTZ-232) targeting advanced metastatic colorectal cancer and other solid tumors.
Founders & leadership
Ltztherapeutics was founded in 2022 by Robert Li.
RL
Robert LiinFounder, CEO
Investors · 1
Frequently asked questions
- What does Ltztherapeutics do?
- LTZ Therapeutics is a clinical-stage biotechnology company developing myeloid cell-engaging immunotherapies to boost anti-tumor immunity against cancer. Its approach directs myeloid cells to kill tumor cells and reprogram the tumor microenvironment, with a lead candidate (LTZ-232) targeting advanced metastatic colorectal cancer and other solid tumors.
- Who founded Ltztherapeutics?
- Ltztherapeutics was founded by Robert Li in 2022.
- Who are Ltztherapeutics's investors?
- Ltztherapeutics's investors include Qiming Venture Partners.
- Where is Ltztherapeutics headquartered?
- Ltztherapeutics is headquartered in Redwood City, US.